Bioray Pharmaceutical Co., Ltd.

This early-phase study tested a new drug called BRY805 in 13 adults with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety and find the best dose for future studies. The trial was terminated early, so results ar…

This early-phase study tested a new drug called BR105 in 31 adults with advanced cancers that had stopped responding to standard treatments. The main goals were to check the drug's safety, find the best dose, and see if it could shrink tumors. The study was stopped early, so resu…

This early-stage study tested a new drug called BR108 in 8 adults with advanced blood cancers (lymphoma, leukemia, or myelodysplastic syndrome) that had not responded to other treatments. The main goals were to check safety, find the right dose, and see if the drug could shrink t…

This study aimed to see if a new drug called HS632 works the same in the body as the approved allergy drug Xolair (omalizumab). It was planned for healthy male volunteers, but only one person joined before the study was stopped. The main goal was to compare how the body processes…